Cargando…
Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and ability of the resistant phenotype.
A 6-month exposure of ZR-75-1 human breast cancer cells to tamoxifen (1 microM rising to 2 microM). resulted in a fall in oestrogen receptor (ER) levels from 225 fmol mg protein-1 to 56 fmol mg protein-1 while progesterone receptor (PGR) concentration fell from 63 fmol mg protein-1 to undetectable l...
Autores principales: | van den Berg, H. W., Lynch, M., Martin, J., Nelson, J., Dickson, G. R., Crockard, A. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247166/ https://www.ncbi.nlm.nih.gov/pubmed/2713239 |
Ejemplares similares
-
Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line.
por: Long, B., et al.
Publicado: (1992) -
Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen.
por: van den Berg, H. W., et al.
Publicado: (1987) -
High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
por: van den Berg, H. W., et al.
Publicado: (1990) -
Overexpression of MTA1 inhibits the metastatic ability of ZR-75-30 cells in vitro by promoting MTA2 degradation
por: Zhang, Long, et al.
Publicado: (2019) -
ZR-75-1 breast cancer models to study the utility of (18)F-FES by PET imaging
por: Ding, Ziteng, et al.
Publicado: (2021)